The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)
Open accessAbstract
Background: Prognostic factors for the Coronavirus disease 2019 (COVID1–9) are not well established. This study aimed to summarize the available data on the association between the severity of COVID-19 and common hematological, inflammatory and biochemical parameters. Methods: EMBASE, MEDLINE, Web of sciences were searched to identify all published studies providing relevant data. Random-effects meta-analysis was used to pool effect sizes. Results: The bibliographic search yielded 287 citations, 31 of which were finally retained. Meta-analysis of standardized mean difference (SMD) between severe and non-severe COVID-19 cases showed that CK-MB (SMD = 0.68,95%CI: 0.48;0.87;P-value:< 0.001), troponin I (SMD = 0.71, 95%CI:0.42;1.00;P-value:< 0.001), D-dimer (SMD = 0.54,95%CI:0.31;0.77;P-value:< 0.001), prothrombin time (SMD = 0.48, 95%CI:0.23;0.73;P-value:< 0.001), procalcitonin (SMD = 0.72, 95%CI: 0.34;1,11;P-value:< 0.001), interleukin-6 (SMD = 0.93, 95%CI: 0.25;1.61;P-value:0.007),C-reactive protein (CRP) (SMD = 1.34, 95%CI:0.83;1.86;P-value:< 0.001), ALAT (SMD = 0.53, 95%CI: 0.34;0,71;P-value:< 0.001), ASAT (SMD = 0.96, 95%CI: 0.58;1.34;P-value:< 0.001), LDH (SMD = 1.36, 95%CI: 0.75;1.98;P-value:< 0.001), CK (SMD = 0.48, 95%CI: 0.10;0.87;P-value:0.01), total bilirubin (SMD = 0.32, 95%CI: 0.18;0.47;P-value:< 0.001), γ-GT (SMD = 1.03, 95%CI: 0.83;1.22;P-value:< 0.001), myoglobin (SMD = 1.14, 95%CI: 0.81;1.47;P-value:< 0.001), blood urea nitrogen (SMD = 0.32, 95%CI: 0.18;0.47;P-value:< 0.001) and Creatininemia (SMD = 0.18, 95%CI: 0.01;0.35;P-value:0.04) were significantly more elevated in severe cases, in opposition to lymphocyte count (SMD = -0.57, 95%CI:-0.71; − 0.42;P-value:< 0.001) and proportion of lymphocytes (SMD = -0.81, 95%CI: − 1.12; − 0.49;P-value:< 0.001) which were found to be significantly lower in severe patients with other biomarker such as thrombocytes (SMD = -0.26, 95%CI: − 0.48; − 0.04;P-value:0.02), eosinophils (SMD = − 0.28, 95%CI:-0.50; − 0.06;P-value:0.01), haemoglobin (SMD = -0.20, 95%CI: − 0.37,-0.03;P-value:0.02), albuminemia (SMD-1.67,95%CI -2.40; − 0.94;P-value:< 0.001), which were also lower. Furthermore, severe COVID-19 cases had a higher risk to have lymphopenia (RR =1.66, 95%CI: 1.26;2.20;P-value:0.002), thrombocytopenia (RR = 1.86, 95%CI: 1.59;2.17;P-value: < 0.001), elevated procalcitonin level (RR = 2.94, 95%CI: 2.09–4.15;P-value:< 0.001), CRP (RR =1.41,95%CI: 1.17–1.70;P-value:0.003), ASAT(RR =2.27, 95%CI: 1.76;2.94;P-value:< 0.001), CK(RR = 2.61, 95%CI: 1.35;5.05;P-value: 0.01), Creatininemia (RR = 3.66, 95%CI: 1.53;8.81;P-value: 0.02) and LDH blood level (RR = 2.03, 95%CI: 1.42;290;P-value: 0.003). Conclusion: Some inflammatory (procalcitonin, CRP), haematologic (lymphocyte, Thrombocytes), and biochemical (CK-MB, Troponin I, D-dimer, ASAT, ALAT, LDH, γ-GT) biomarkers are significantly associated with severe COVID-19. These biomarkers might help in prognostic risk stratification of patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349
Assessing heterogeneity in meta-analysis: Q statistic or I² index?
Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.2.193 · Cited by 4,256
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339
Humoral Innate Immunity and Acute-Phase Proteins
Mantovani, A., & Garlanda, C. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2206346 · Cited by 310
A time-resolved proteomic and prognostic map of COVID-19
Demichev, V., Tober-Lau, P., Lemke, O., Nazarenko, T., Thibeault, C., Whitwell, H., Röhl, A., Freiwald, A., Szyrwiel, L., Ludwig, D., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.005 · Cited by 200
Metadata
- Authors
- Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D. L. A., Robert, A., & Noubiap, J. J.
- Venue
- Biomarker Research
- Published
- 2020-08-31
- Volume
- 8
- Issue
- 1
- Pages
- 37-37
- ISSN
- 2050-7771 (ISSN-L)
- OpenAlex
- W3082012811
- Cited by
- 167
- References
- 19
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). https://app.cochat.ai/papers/10.1186/s40364-020-00217-0
- The paper
- Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D. L. A., Robert, A., & Noubiap, J. J. (2020). A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomarker Research. https://doi.org/10.1186/s40364-020-00217-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.